KASMEJ

Kastamonu Medical Journal regularly publishes internationally qualified issues in the field of Medicine in the light of up-to-date information.

EndNote Style
Index
Original Article
Antibiotic susceptibility of staphylococcus aureus strains isolated from various clinical specimens in a tertiary hospital
Aims: Staphylococcus aureus infection rates, which are the cause of infections, have rapidly risen in both hospitals and society, constituting a concern. In this study, it was aimed to examine the antibiotic susceptibility of S. aureus strains isolated from patients treated in a tertiary state hospital for four years.
Methods: A retrospective analysis was performed on S. aureus strains (n=584) identified from clinical samples delivered to the medical microbiology laboratory of Niğde Ömer Halisdemir University Training and Research Hospital for bacterial culture between 2016 and 2019. The isolates were identified by standard laboratory procedure. VITEK 2 automated system (bioMerieux, France) was used to identification and antibiotic susceptibilities of evaluate the strains.
Results: Strains were most commonly isolated from wound swab (n=173) and blood culture (n=107). While the highest resistance rate was observed against Erythromycin (n=232), the least amikacin (n=16) resistant strain was determined. Vancomycin and teicoplanin resistance was not observed.
Conclusion: Multi-drug resistance and MRSA resistance still exist today. The absence of vancomycin and teicoplanin resistance, in addition to the low level of trimethoprim-sulfamethoxazole resistance, is encouraging. This information about S. aureus's susceptibility may be helpful in determining how to administer antibiotics.


1. Pollitt EJ, Szkuta PT, Burns N, et al. Staphylococcus aureus infectiondynamics. PLoS Pathog. 2018;14(6):e1007112.
2. Sig AK, Duran AÇ, Atik TK, Ozen N, Irmak O,Yarar M. Distribution ofclinical Staphylococcus aureus isolates and antibiotic resistance profile:three-year data. J Contemp Med. 2022;12(6):984-988.
3. Guo H, Tong Y, Cheng J, et al. Biofilm and small colony variants—anupdate on Staphylococcus aureus strategies toward drug resistance. Int JMol Sci. 2022;23(3):1241.
4. Guo Y, Song G, Sun M, et al. Prevalence and therapies of antibiotic-resistance in Staphylococcus aureus. Front Cell Infect Microbiol.2020;10:107.
5. Tayeb-Fligelman E, Tabachnikov O, Moshe A, et al. The cytotoxicStaphylococcus aureus PSMα3 reveals a cross-α amyloid-like fibril. Science.2017;355(6327):831-833.
6. Pal M, Gutama KP, Koliopoulos T. Staphylococcus aureus, an importantpathogen of public health and economic importance: a comprehensivereview. J Environ Health Sci Eng. 2021;4:17-32.
7. Bruce SA, Smith JT, Mydosh JL, et al. Shared antibiotic resistance andvirulence genes in Staphylococcus aureus from diverse animal hosts. Sci Rep.2022;12(1):1-11.
8. Vestergaard M, Frees D, Ingmer H. Antibiotic resistance and the MRSAproblem. Microbiol Spectrum. 2019;7(2): 7-2.
9. Cheung GYC, Bae JS, Otto M. Pathogenicity and virulence ofStaphylococcus aureus. Virulence. 2021;12(1):547-69.
10. Falagas ME, Karageorgopoulos DE, Leptidis J, et al. MRSA in Africa:Filling the global map of antimicrobial resistance. PloS one. 2013;8:e68024.
11. Mlynarczyk-Bonikowska B, Kowalewski C, Krolak-Ulinska A, et al.molecular mechanisms of drug resistance in Staphylococcus aureus. Int JMol Sci. 2022;23(15):8088.
12. Duran H, Çeken N, Atik TK. Çeşitli klinik örneklerden izole edilenStaphylococcus aureus suşlarının antibiyotik direnç oranları. TurkMikrobiyol Cem Derg. 2021;51(3):233-238.
13. Muhammad A, Khan SN, Ali N, et al. Prevalence and antibioticsusceptibility pattern of uropathogens in outpatients at a tertiary carehospital. NMNI. 2020;36:100716.
14. Önder I, Kilinç Ç, Güçkan R, et al. Üçüncü basamak bir hastanedestafilokok türlerinde fusidik asit ve diğer antibiyotiklerin duyarlılıklarınınaraştırılması. Abant Med J. 2016;5(2):101-107.
15. European Committee on Antimicrobial Susceptibility Testing (EUCAST)Breakpoint tables for interpretation of MICs and zone diameters. Version11, (2021). Available from: http://www.eucast.org.
16. Salmanov A, Shchehlov D, Artyomenko V, et al. Nosocomial transmissionof multi-drug-resistant organisms in Ukrainian hospitals: results of amulti-centre study (2019-2021). J Hosp Infect. 2023;132:104-115.
17. Hosaka Y, Yahara K, Clark A, et al. Surveillance of multi-drug resistancephenotypes in Staphylococcus aureus in Japan and correlation with whole-genome sequence findings. J Hosp Infect. 2022;123:34-42.
18. Doğan B, Palaz M, Izgür M. Metisilin dirençli Staphylococcus aureus veönemi. Etlik Vet Mikrobiyol Derg. 2018;29(2):157-161.
19. Şenol FF, Seyrek A, Aytaç Ö. Çeşitli klinik örneklerden izole edilenstafilokoklara karşı moksifloksasin duyarlılığının araştırılması. Fırat TıpDerg. 2022;27(3):197-201.
20. Güngör S, Karaayak Uzun B, Gül Yurtsever S, et al. Kan kültürlerindenizole edilen Staphylococcus aureus suşlarında antibiyotiklere direnç.Ankem Derg. 2012;26(4):171-175.
21. Stefanaki C, Ieronymaki A, Matoula T, et al. Six-year retrospective reviewof hospital data on antimicrobial resistance profile of Staphylococcusaureus isolated from skin infections from a single institution in Greece.Antibiotics. 2017;6(4):39.
22. Lim WW, Wu P, Bond HS, et. al. Determinants of methicillin-resistantStaphylococcus aureus (MRSA) prevalence in the Asia-Pacific region: Asystematic review and meta-analysis. J Glob Antimicrob Resist. 2019;16:17-27.
23. Arora S, Devi P, Arora U, et al. Prevalence of methicillin-resistantStaphylococcus aureus (MRSA) in a tertiary care hospital in NorthernIndia. J Lab Physicians. 2010;2(2):78-81.
24. Skov R, Larsen AR, Kearns A, et al. Phenotypic detection of mecC-MRSA: cefoxitin is more reliable than oxacillin. J Antimicrob Chemother.2013;69:133-138.
25. Ayvalik T, Çetin ES, Şirin MC, et al. Yoğun bakim ünitesinde yatanhastalarin endotrakeal aspirat örneklerinden izole edilen bakterilerinantibiyotik direnç oranlari. Med J SDU. 2022;29:398-404.
26. Yüksekkaya Ş, Opuş A, Güvenç HI, et al. 2009-2013 yillari arasindaKonya Eğitim ve Araştirma Hastanesi’nde kan kültüründen izole edilenStaphylococcus aureus suşlarinin antimikrobiyal ajanlara duyarliliklarinindeğerlendirilmesi. Ankem Derg. 2017;31(1):1-6.
27. Ulusal Antimikrobiyal Direnç Surveyans Sistemi,. 2013 Yıllık Raporu,Türkiye Halk Sağlığı Kurumu, Sağlık Bakanlığı Ankara,(2013). URL:http://uamdss.thsk.gov.tr (date of access: 10/12/2022).
28. Eksi F, Gayyurhan ED, Bayram A, et al. Determination of antimicrobialsusceptibility patterns and inducible clindamycin resistance inStaphylococcus aureus strains recovered from southeastern Turkey. JMicrobiol Immunol Infect. 2011;44(1):57-62.
29. Özel Y, Büyükzengin KB,Yavuz MT. Klinik örneklerden izole edilenmetisiline dirençli ve duyarlı Staphylococcus aureus suşlarının antibiyotikdirenç profilinin araştırılması. ANKEM Derg. 2017;31(2):41-47.
30. Çay Ü, Celik U, Barutçu A, Ozdemir U, Ünal N. Clinical characteristicsand resistance patterns of Staphylococcus aureus infections in children at atertiary care hospital in southern Turkey. Cukurova Med J. 2022;47(2):580-8.
31. Tanriverdi ES, Duman Y, Tekerekoğlu MS. Bir üniversite hastanesinde.2018-2019 yıllarında izole edilen Staphylococcus aureus izolatlarınınincelenmesi. Fırat Tıp Derg. 2020;25(4):184-188.
32. Arabacı Ç, Uzun B. Staphylococcus aureus izolatlarının çeşitliantibiyotiklere duyarlılıklarının değerlendirilmesi. Klimik J.2021;34(1):69-74.
33. Kula-Atik T, Uzun B. Kan kültürlerinden izole edilen Staphylococcusaureus suşlarının metisiline ve diğer antimikrobiyal ajanlara dirençdurumlarının değerlendirilmesi. Klimik J. 2020;33(2):132-136.
34. Şanlı K, Kömürcü SZM, Kansak N, Adaleti R. Staphylococcus aureus’ unonbeş yılda metisilin direnç ve antibiyogram direnç profilinin ve görülmesıklığının değişimi. Türk Mikrobiyol Cem Derg. 2021;51(1):15-22.
35. La Vecchia A, Ippolito G, Taccani V, et al. Epidemiology and antimicrobialsusceptibility of Staphylococcus aureus in children in a tertiary carepediatric hospital in Milan, Italy,. 2017-2021. Ital J Pediatr. 2022;48:1-8.
Volume 3, Issue 2, 2023
Page : 55-59
_Footer